Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Ares prepares European sports fund as push into private wealth accelerates
Ares prepares European sports fund as push into private wealth accelerates Ares Management is preparing to expand its sports investment strategy into Europe with a new sports, media, and entertainment opportunities fund targeting wealthy individuals, according to...
From NFL glory to $3.2bn private equity win: Steve Young’s HGGC beats target
From NFL glory to $3.2bn private equity win: Steve Young’s HGGC beats target HGGC has raised $3.2bn for its fifth flagship fund, surpassing both its $2.5bn target and $2.8bn hard cap despite a muted global fundraising backdrop, according to a report by Bloomberg. The...
Moonfare closes $83m Co-Investment Fund II, exceeding target in 12 months
Moonfare closes $83m Co-Investment Fund II, exceeding target in 12 months Moonfare has closed Moonfare Co-Investment Fund II at $83m, surpassing its target within 12 months and marking a 43% increase on its prior vintage. The second-generation vehicle builds on...